Álvaro Proaño
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
Also affiliated: Tulane University (2020–2023); National Institutes of Health (2017); Children's Hospital of Philadelphia (2023–2026); Johns Hopkins University (2019); Universidad Peruana Cayetano Heredia (2011–2019); University of Arkansas Medical Center (2026); Alberto Hurtado University (2017); International Center for Transitional Justice (2022); University of Pennsylvania (2024–2026)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Álvaro Proaño's research investigates health challenges in diverse populations, with a focus on infectious diseases and maternal and child health. He has contributed to a systematic review and meta-analysis on risk factors for vertical transmission of Chagas disease and has published work examining Chagas disease diagnostic testing and targeted screening strategies. His research also extends to the application of telemedicine in pediatric care within low- and middle-income countries and the evaluation of social media use within the neonatal-perinatal community.
Proaño's work addresses critical issues in neonatology, including bias and knowledge gaps related to race and ethnicity in manuscript review. He also examines the long-term health effects of preterm birth, specifically its impact on growth and blood pressure in adulthood. His scholarship metrics include an h-index of 10, with 34 total publications and 384 total citations.
Metrics
- h-index: 10
- Publications: 35
- Citations: 404
Selected Publications
-
Anti-cytomegalovirus medications among very low birth weight infants in the United States from 2016 to 2023 (2026)
Collaboration Network
Top Collaborators
- Anti-cytomegalovirus medications among very low birth weight infants in the United States from 2016 to 2023
- Anti-cytomegalovirus medications among very low birth weight infants in the United States from 2016 to 2023
- Anti-cytomegalovirus medications among very low birth weight infants in the United States from 2016 to 2023
- Anti-cytomegalovirus medications among very low birth weight infants in the United States from 2016 to 2023
- Anti-cytomegalovirus medications among very low birth weight infants in the United States from 2016 to 2023
Similar Researchers
Based on overlapping research topics